David Eichenbaum, MD

In an interview, David Eichenbaum, MD, director of research at Retina Vitreous Associates of Florida, discussed:

how he approaches managing DME treatment, and how best to educate patients on how to be aware of DME;
how he coordinates with other providers when treating DME, and his process for keeping all parties properly informed;
the latest on emerging treatments in DME, specifically the widespread use of faricimab (Vabysmo, G enentech);
how implicit bias, both racial and gender-based, impacts the treatment and diagnosis of DME;
important areas of unmet need in DME, especially the need for greater patient education;
and how the COVID-19 pandemic changed DME treatment, and how treatment has further shifted as patients return to doctor's offices in person.

DME Awareness